Subscribe

Paying for Miracles:
The Math and Morals
of Million-Dollar Cures

Ahmed Elsayyad

May 21, 2025

7 Minute Read

Read More

Articles

June 5, 2025
11 Minute Read

Bypassing the Gatekeepers, Cautiously: Marketers and the New Era of Life Sciences DTC

Larry Dobrow
May 28, 2025
8 Minute Read

The Final Frontier: How Medical-Commercial Collaboration Can Reinvent Unbranded Campaigns

Tyler Redelico
May 21, 2025
7 Minute Read

Paying for Miracles: The Math and Morals of Million-Dollar Cures

Ahmed Elsayyad
May 15, 2025
11 Minute Read

Life-Saving Data Points and 30,000-Foot Views: GSK Analytics Whisperer Nivi Mogali Redefines the Role

Larry Dobrow
May 8, 2025
12 Minute Read

How Pharma Learned to Love Patient and Physician Influencers

Larry Dobrow
May 1, 2025
8 Minute Read

Transforming Maternal Mental Health: A Q&A with Sage Therapeutics CEO Barry Greene

Chase Feiger
April 22, 2025
8 Minute Read

Fast Takeoff Versus Gradual Ramp-Up: The Scaling Hypothesis Comes to Pharma

Ahmed Elsayyad
April 17, 2025
9 Minute Read

The Improbable Resilience of the Life Sciences TV Ad

Larry Dobrow
April 10, 2025
7 Minute Read

Advancing Neurohealth: A Q&A with Alkermes CEO Richard Pops

Chase Feiger
April 3, 2025
7 Minute Read

‘No Innovation for Innovation’s Sake’: Inside Endo’s Spatial Computing Gambit

Larry Dobrow
March 27, 2025
8 Minute Read

Innovate or Become Obsolete: Pharma’s AI Imperative

Will McMahon, Director, Omnichannel Strategy, AstraZeneca
March 20, 2025
9 Minute Read

Building a First-Tier Pharma Culture: A Q&A with Jazz Pharmaceuticals CEO Bruce Cozadd

Chase Feiger
Load More

Kinara

Social

© 2025 Kinara. All rights reserved. Terms of Use. Privacy Policy.

Kinara